Business Standard
Monday, May 28, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||Companies & Industry||||||| 
 Section Home | News Now | Today's Paper | Q&A | People in the News | Industry News | Features | The Compass | Research & Analysis | Opinion | Corporate Results
Home > Companies & Industry Live Markets | Commodities
 

GSK to start shipping swine flu vaccine next week
AFP/ PTI / London Sep 30, 2009, 19:43 IST

British drugmaker GlaxoSmithKline (GSK) will next week begin shipping its swine flu vaccine Pandemrix across Europe, the group announced today following approval by regulators.

"Following the (European) Commission's approval we expect to commence shipments of Pandemrix to European governments from next week," said Jean Stephenne, President of GlaxoSmithKline Biologicals, in a company statement.

The news came one day after the European Commission cleared Pandemrix and another vaccine, Focetria, for distribution in Europe. Focetria is produced by Swiss pharmaceuticals group Novartis.

"GSK confirmed today that the European Commission has granted marketing authorisation of GSK's pandemic (H1N1) adjuvanted vaccine Pandemrix for protection against pandemic H1N1 2009 influenza," the group added today.

The decision on the two vaccines was pushed through last week by the European Medicines Agency amid deep concern about the new winter influenza season and an upturn in British cases of swine flu.

Health experts have meanwhile warned of a second wave of flu in the coming months as the northern hemisphere winter approaches.

The commission had announced yesterday that the vaccines will be authorised for use in all 27 EU member nations as well as Iceland, Liechtenstein and Norway. The authorisation was expected to take effect by October 1.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Markets end on a strong note
- Easing inflation a positive for China rating: Moody's
- Falling oil price, gold import to help CAD in short-term: Kotak
- Silver moves up on higher global cues
- Shortage of petrol, diesel hits Chennai
  Read Business news in 
- Journey on, We are by Your Side. Click here to know more
- 2 Lac Apartments, 1 Lac House / Plots. Click here
- Help a Child Achieve her. Click to know more
- Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol.
- The Best Seller is Also the No. 1 in Mileage. Click here
- Watch The Film Here. Click here to know more..
- Leader in Passenger Car & Automobile Tyres. Click here
- 1 billion in saving for Unilever without any tangles.
- A Brand New Server at a Price That Fits Your Budget. Click here
- Learn How One City is Running on FOOD SCRAPS.
- One Partnership Endless Possibilities. Click here to know more
- Helping doctors detect diseases earlier, saving costs & extending lives.
- 36 Lakhs can get you a pool of Luxuries. Click here
- Which is the best plan for your daughter
- Check out the TRUE COLOURS of your Stocks, Now for FREE!
- One of the leading business schools in the world.Know More
Sorry, comments to this story are closed
Latest Messages
Table for Two
  Now available at Special price
  Rs.280/- Only

  Buy Now
BS POLL
UPA 2 has completed three years. How do you rate its performance?  Read the story
  Good
  Average
  Bad
Submit
Most Popular
Read
E-Mailed
Commented
   
- NRIs likely to be allowed to invest through new route
- RIL wants import-parity price for its gas
- Renu Kohli: Rupee: depreciated tactics
- Gold imports fall 32% on strict govt measures
- Mobile handset companies bet on Indian app makers
 
 More  
Tax Shastra
  Now available at Special price
  Rs. 360/- Only

  Buy Now
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World | General News
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us